SK Biopharmaceuticals Co. has signed an MOU with PhnyX Lab to jointly develop AI-powered solutions for automating drug discovery processes, aiming to boost global competitiveness.
#YonhapInfomax #SKBiopharmaceuticals #PhnyXLab #AIDrugDevelopment #Cheiron #MOU #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68036
#YonhapInfomax #SKBiopharmaceuticals #PhnyXLab #AIDrugDevelopment #Cheiron #MOU #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68036